✦ LIBER ✦

Prospective Trial of Pre-Transplant 5-Azacitidine on Hematopoietic Cell Transplantation Outcomes for Myelodysplastic Syndrome and CMML

✍ Scribed by T.L. Field; J. Perkins; J. Pidala; T. Nishihori; M. Tomblyn; H. Fernandez; L. Perez; M.A. Karfan-Dabaja; R. Komrokji; J. Lancet; E. Ayala; M. Alsina; L. Ochoa; J. Kim; A. List; C. Anasetti

Book ID: 116282409
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 51 KB
Volume: 17
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2010.12.473

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prospective Trial of Pre-Transplant 5-Az

Prospective Trial of Pre-Transplant 5-Azacitidine on Hematopoietic Cell Transplantation Outcomes for Myelodysplastic Syndrome and CMML

✍ T. Field; J. Perkins; T. Nishori; J. Pidala; H.F. Fernandez; M. Tomblyn; M. Khar 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Pre-Transplant Azacitidine and Allogenei

Pre-Transplant Azacitidine and Allogeneic Hematopoietic Cell Transplant (HCT) Outcomes of One Hundred Fifty-Nine Patients up to Age Seventy-Five with Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML)

✍ Field, Teresa; Perkins, Janelle; Hillgruber, Ryan; Nishihori, Taiga; Tomblyn, Ma 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Allogeneic hematopoietic cell transplant

Allogeneic hematopoietic cell transplantation for myelodysplastic syndrome: prognostic significance of pre-transplant IPSS score and comorbidity

✍ Lee, J-H; Lee, J-H; Lim, S-N; Kim, D-Y; Kim, S H; Lee, Y-S; Kang, Y-A; Kang, S-I 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 185 KB

Impact of Conditioning Regimen Intensity

Impact of Conditioning Regimen Intensity on Outcome of Allogeneic Hematopoietic Cell Transplantation for Advanced Acute Myelogenous Leukemia and Myelodysplastic Syndrome

✍ Edwin P. Alyea; Haesook T. Kim; Vincent Ho; Corey Cutler; Daniel J. DeAngelo; Ri 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 208 KB

Long-Term Outcomes of Alemtuzumab-Based

Long-Term Outcomes of Alemtuzumab-Based Reduced-Intensity Conditioned Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome and Acute Myelogenous Leukemia Secondary to Myelodysplastic Syndrome

✍ Potter, Victoria T.; Krishnamurthy, Pramila; Barber, Linda D.; Lim, ZiYi; Kenyon 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 595 KB

The Novel 5-Group Cytogenetic Risk Class

The Novel 5-Group Cytogenetic Risk Classification of Myelodysplastic Syndrome (MDS), Monosomal Karyotype, and Outcome After Allogeneic Hematopoietic Cell Transplantation (HCT)

✍ A. Gerds; T. Gooley; B.L. Scott; F.R. Appelbaum; H.J. Deeg 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 62 KB